Lobbying Activity Report

5288-43349

Organization: Moderna Biopharma Canada Corporation
Associated registration: 9939-5288-8
Lobbying Activity date: 2025-05-15
Arranged a meeting: No
Posted date: 2025-06-13

In-house lobbyists who participated in the lobbying activity: Laura Fitzgerald
Senior Public Office Holders who were lobbied in this activity: Nina Cagic, Director, Investor Services, Technology
Jobs, Economic Development and Innovation

Maija Duffy, Executive Director, Technology and Life Sciences
Jobs, Economic Development and Innovation

Cecile Lacombe, Executive Project Director, Research & Life Sciences
Jobs, Economic Development and Innovation
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Communication with the BC Government and its stakeholders to advance a pro-innovation business environment for the life sciences sector. The aim is to foster an environment that encourages the development, trialing and adoption of innovative solutions in the life sciences sector, particularly those that leverage the groundbreaking mRNA technology.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Advanced Education, Economic Development and Trade, Health, Science and Technology
Policy and program recommendations regarding the government's stimulus response measures related to COVID-19 and economic recovery.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
 Advanced Education, COVID-19, Economic Development and Trade, Finances and Budgets, Government Procurement, Health, Hospitals, Science and Technology, Senior Citizens
Recommendations regarding job creation and growth of BC's knowledge-based economy. Business incentives for and/or barriers to investment in BC. Sharing of information on Moderna’s global mRNA research investment platform and opportunities for increased investment in BC.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Advanced Education, Economic Development and Trade, Health, Science and Technology
 
Senior officer who filed this Lobbying Activity Report: Stefan Raos
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Return to Registration for Western Canada Wilderness Committee
Date Modified: